Drugmakers face clinical trial disruptions amid Russia - Ukraine conflict (NYSE:ABT)

The war between Russia and Ukraine has placed U.S. pharma giants conducting clinical trials in the two countries in a tight spot

Related Keywords

Germany ,United States ,Netherlands ,Russia ,Ukraine ,Russian ,American ,Dutch ,German ,Angela Hwang ,Joseph Wolk ,Caroline Litchfield ,Bristol Myers Squibb ,Tarsis Lopez ,Yale University ,World Health Organization ,Al Jazeera ,Sp Global Inc ,Chief Financial Officer Caroline Litchfield ,Eli Lilly ,Eastern Europe ,Allegan Aesthetics ,Thermo Fisher Scientific ,Thewall Street Journal ,Chief Financial Officer ,Some European ,